Catalyst Wire Dossier Catalyst Wire Dossier

Esmeron

rocuronium · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Esmeron, covering 2017-08-22 to 2019-02-01. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of Sugammadex (Org 25969; MK-8616) at 3 Different Time Points After 0.6 mg/kg Esmeron® in Male Participants (P05940; MK-8616-020). [Phase 2]

See pricing